临床-梗死不匹配筛选儿童卒中取栓:Save ChildS研究分析
该研究为Save ChildS研究的二次分析,纳入20例经临床-梗死不匹配筛选、在症状发作后6至24小时行血管内取栓的儿童动脉缺血性卒中患者。结果显示取栓安全,神经功能结局总体良好,3个月mRS中位数1.0,24个月为0.0,仅1例出现短暂围术期血管痉挛。
要点
- 儿童卒中发病6至24小时取栓,经临床-梗死不匹配筛选,安全且结局良好。
- 20例患儿中位年龄10.5岁,中位发病至取栓时间9.8小时。
- 3个月mRS中位数1.0,24个月0.0,仅1例短暂围术期血管痉挛。
核心结论
- 对于临床缺损与梗死体积不匹配的儿童动脉缺血性卒中,症状发作后24小时内行取栓似乎安全,神经功能结局总体良好。
研究设计与样本
- Save ChildS研究(2000年1月至2018年12月)的二次分析,纳入27家欧洲和美国卒中中心的儿童(<18岁)动脉缺血性卒中并接受血管内再通治疗的患者。
- 共纳入20例经临床-梗死不匹配筛选的患儿,中位年龄10.5岁(IQR 7-14.6),男性7例(35%)。
主要发现
- 中位发病至取栓时间9.8小时(IQR 7.8-16.2)。
- 中位Pediatric NIH Stroke Scale评分从入院12.0(IQR 8.8-20.3)改善至第7天2.0(IQR 1.2-6.8)。
- 中位mRS评分3个月为1.0(IQR 0-1.6),24个月为0.0(IQR 0-1.0)。
- 1例出现短暂围术期血管痉挛,未观察到其他并发症。
- 与DAWN和DEFUSE 3试验相比,儿童人群良好结局比例更高。
关键数值与推荐
- 纳入标准为临床缺损与梗死之间存在相关不匹配。
- 证据等级为Class IV,表明对于临床缺损与梗死体积不匹配的儿童急性缺血性卒中,取栓是安全的。
临床怎么用
- 儿童卒中发病6至24小时,可考虑以临床-梗死不匹配筛选患者行取栓治疗。
- 需注意该研究为Class IV证据,临床决策应结合个体情况。
局限性
- 样本量小(20例),为二次分析,证据等级Class IV。
- 未设对照组,无法直接比较取栓与保守治疗的效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether thrombectomy is safe in children up to 24 hours after onset of symptoms when selected by mismatch between clinical deficit and infarct. METHODS: A secondary analysis of the Save ChildS Study (January 2000-December 2018) was performed, including all pediatric patients (<18 years) diagnosed with arterial ischemic stroke who underwent endovascular recanalization at 27 European and United States stroke centers. Patients were included if they had a relevant mismatch between clinical deficit and infarct. RESULTS: Twenty children with a median age of 10.5 (interquartile range [IQR] 7-14.6) years were included. Of those, 7 were male (35%), and median time from onset to thrombectomy was 9.8 (IQR 7.8-16.2) hours. Neurologic outcome improved from a median Pediatric NIH Stroke Scale score of 12.0 (IQR 8.8-20.3) at admission to 2.0 (IQR 1.2-6.8) at day 7. Median modified Rankin Scale (mRS) score was 1.0 (IQR 0-1.6) at 3 months and 0.0 (IQR 0-1.0) at 24 months. One patient developed transient peri-interventional vasospasm; no other complications were observed. A comparison of the mRS score to the mRS score in the DAWN and DEFUSE 3 trials revealed a higher proportion of good outcomes in the pediatric compared to the adult study population. CONCLUSIONS: Thrombectomy in pediatric ischemic stroke in an extended time window of up to 24 hours after onset of symptoms seems safe and neurologic outcomes are generally good if patients are selected by a mismatch between clinical deficit and infarct. CLASSIFICATION OF EVIDENCE: This study provides Class IV evidence that for children with acute ischemic stroke with a mismatch between clinical deficit and infarct size, thrombectomy is safe.
引用
- Sporns PB, Psychogios MN, Straeter R, et al. Clinical Diffusion Mismatch to Select Pediatric Patients for Embolectomy 6 to 24 Hours After Stroke: An Analysis of the Save ChildS Study. Neurology. 2020. PMID: 33144517. doi:10.1212/WNL.0000000000011107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。